Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer (TAPS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by University of Washington.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
GlaxoSmithKline
AstraZeneca
Information provided by (Responsible Party):
Bruce Montgomery, University of Washington
ClinicalTrials.gov Identifier:
NCT00298155
First received: February 27, 2006
Last updated: January 6, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2012
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
No publications provided by University of Washington

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):